Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study-Reference-Cited by-同舟云学术

Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study

Published:2024-01-06 Issue:7 Volume:49 Page:1113-1119
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol.

Author:

Koch Elise^ORCID,Kämpe Anders,Alver Maris,Sigurðarson Sindri,Einarsson Guðmundur,Partanen Juulia,Smith Robert L.,Jaholkowski Piotr,Taipale Heidi,Lähteenvuo Markku,Steen Nils Eiel^ORCID,Smeland Olav B.^ORCID,Djurovic Srdjan^ORCID,Molden Espen^ORCID, , ,Sigurdsson Engilbert,Stefánsson Hreinn,Stefánsson Kári,Palotie Aarno,Milani Lili,O’Connell Kevin S.,Andreassen Ole A.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41386-023-01792-0.pdf

Reference44 articles.

1. Yoshida K, Takeuchi H. Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophrenia. Behav Brain Res. 2021;402:113098.

2. Denny JC, Collins FS. Precision medicine in 2030-seven ways to transform healthcare. Cell. 2021;184:1415–9.

3. Njolstad PR, Andreassen OA, Brunak S, Borglum AD, Dillner J, Esko T, et al. Roadmap for a precision-medicine initiative in the Nordic region. Nat Genet. 2019;51:924–30.

4. Zheutlin AB, Dennis J, Karlsson Linner R, Moscati A, Restrepo N, Straub P, et al. Penetrance and pleiotropy of polygenic risk scores for schizophrenia in 106,160 patients across four health care systems. Am J Psychiatry. 2019;176:846–55.

5. Wettermark B, Zoega H, Furu K, Korhonen M, Hallas J, Norgaard M, et al. The Nordic prescription databases as a resource for pharmacoepidemiological research-a literature review. Pharmacoepidemiol Drug Saf. 2013;22:691–9.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Real-World Data Can Facilitate the Development of Precision Medicine Treatment in Psychiatry;Biological Psychiatry;2024-10

2. Genome-wide association analysis of treatment resistant schizophrenia for variant discovery and polygenic assessment;2024-07-18